Evidence map›Paper›PMID 30884531›Full record

ArticleInvestigative ophthalmology & visual science2019

Descemet's Membrane Modulation of Posterior Corneal Fibrosis.

Carla S Medeiros, Paramananda Saikia, Rodrigo Carlos de Oliveira, Luciana Lassance, Marcony R Santhiago, Steven E Wilson

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Healed Perforated Corneal Ulcers in Human.Life (Basel, Switzerland) · 2025
    Article
  5. Establishment of an Ex Vivo Human Corneal Endothelium Wound Model.Translational vision science & technology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Review
  12. Article
  13. Review
  14. Magic Bullets: The Coming Age of Meaningful Pharmacological Control of the Corneal Responses to Injury and Disease.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. [Corneal wound healing-Pathophysiology and principles].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Carla S MedeirosCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Paramananda SaikiaCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Rodrigo Carlos de OliveiraCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Luciana LassanceCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Marcony R SanthiagoDepartment of Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil.
Steven E WilsonCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Cleveland Eye Clinic · USCleveland Clinic · USUniversidade de São Paulo · BR

Funding

RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI BELA ANAND-APTE · 2016 to 2026
$7.7M
Corneal Epithelial Growth Factors and ReceptorsR01EY010056 · NEI · UNIVERSITY OF WASHINGTON · PI WILSON, STEVEN EUGENE · 1994 to 2020
$7.4M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY010056NEI NIH HHS T32 EY007157
6 · The paper itself

Abstract

Purpose: The purpose of this study was to evaluate the effect of removal of Descemet's basement membrane and endothelium compared with removal of the endothelium alone on posterior corneal fibrosis. Methods: Twelve New Zealand White rabbits were included in the study. Six eyes had removal of the Descemet's membrane-endothelial complex over the central 8 mm of the cornea. Six eyes had endothelial removal with an olive-tipped cannula over the central 8 mm of the cornea. All corneas developed stromal edema. Corneas in both groups were cryofixed in optimum cutting temperature (OCT) formula at 1 month after surgery. Immunohistochemistry (IHC) was performed for α-smooth muscle actin (SMA), keratocan, CD45, nidogen-1, vimentin, and Ki-67, and a TUNEL assay was performed to detect apoptosis. Results: Six of six corneas that had Descemet's membrane-endothelial removal developed posterior stromal fibrosis populated with SMA+ myofibroblasts, whereas zero of six corneas that had endothelial removal alone developed fibrosis or SMA+ myofibroblasts (P < 0.01). Myofibroblasts in the fibrotic zone of corneas that had Descemet's membrane-endothelial removal were undergoing both mitosis and apoptosis at 1 month after surgery. A zone between keratocan+ keratocytes and SMA+ myofibroblasts contained keratocan-SMA-vimentin+ cells that were likely CD45- corneal fibroblasts and CD45+ fibrocytes. Conclusions: Descemet's basement membrane has an important role in modulating posterior corneal fibrosis after injury that is analogous to the role of the epithelial basement membrane in modulating anterior corneal fibrosis after injury. Fibrotic areas had myofibroblasts undergoing mitosis and apoptosis, indicating that fibrosis is in dynamic flux.

Indexed as

ActinsAnimalsApoptosisCorneal EdemaCorneal StromaDescemet MembraneFemaleFibrosisImmunohistochemistryIn Situ Nick-End LabelingKi-67 AntigenLeukocyte Common AntigensMembrane GlycoproteinsMitosisMyofibroblastsProteoglycansActinsKi-67 AntigenLeukocyte Common AntigensMembrane GlycoproteinsnidogenProteoglycansVimentin

Identifiers

PMID30884531
PMCPMC6424532
OpenAlexW2921683947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.